TIDMALGW

RNS Number : 6609X

Alpha Growth PLC

22 December 2023

Alpha Growth plc

(" Alpha " or the "Company")

Expiration of Warrants

As announced by the Company on 11 February 2021, pursuant to a placing to raise GBP3.75 million, the Company granted 187,500,000 warrants ("Warrants") to the placees, exercisable at a price of 3 pence per share, for a period of 24 months following the date of grant, being 15 March 2021. As subsequently announced on 6 March 2023, the Directors resolved that, following statements made in announcements in relation to the same, the final exercise date for the Warrants relating to the 2021 placing, was extended to 21 December 2023.

The Company can report that no Warrants have been exercised and that these Warrants have now expired. The Company currently has no other warrants outstanding.

The total outstanding shares in the Company are 467,775,068 and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Alpha Growth plc under the FCA's Disclosure Guidance and Transparency Rules.

** ENDS **

For more information, please visit www.algwplc.com or contact the following:

 
                                              +44 (0) 20 3959 
 Alpha Growth plc                              8600 
 Gobind Sahney, Executive Chairman            info@algwplc.com 
                                              +44 (0) 20 3328 
   Allenby Capital Limited                     5656 
 Amrit Nahal (Sales and Corporate Broking) 
 Nick Athanas / Piers Shimwell (Corporate 
  Finance) 
 
   UK Investor Relations - Mark Treharne      ir@algwplc.com

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

Important Notice

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCPPGCAPUPWGPG

(END) Dow Jones Newswires

December 22, 2023 04:00 ET (09:00 GMT)

Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alpha Growth Charts.
Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alpha Growth Charts.